Entact Bio
Pre-clinicalDevelops targeted protein degradation therapies using molecular glue technology for oncology and immunology.
Founded
2021
Focus
Small Molecules
About
Develops targeted protein degradation therapies using molecular glue technology for oncology and immunology.
Funding History
1SeedUndisclosedUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile